Pharmacist coaching may boost inhaler success in rare lung disease
NCT ID NCT07457762
First seen Mar 17, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study looks at whether guidance from a pharmacist can help people with pulmonary arterial hypertension (PAH) stick to their inhaled medication, iloprost. PAH is a serious lung condition that makes it hard to breathe and can lead to heart failure. The study will enroll 72 adults who already use iloprost and will test if pharmacist support improves how often they take their medicine and reduces side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION PAH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Incor HCFMUSP
RECRUITINGSão Paulo, São Paulo, 01246-000, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.